Imcd N.v. · EURONEXT:IMCD
Imcd — Q1 2022 Earnings Presentation
16 slides from Imcd's earnings presentation, Apr 29, 2022
Slide 1: Welcome to a world of opportunity
Welcome to a world of opportunity CONFERENCE CALL First three months 2022 results 29 April 2022 222
Slide 2: Presenting team
Presenting team Piet van der Slikke Hans Kooijmans Led the formation of IMCD since 1995 Joined IMCD in 1996 Designed and executed IMCD’s strategy Co-led formation of IMCD 27 years of industry experience 26 years of industry experience 2
Slide 3: Company profile
Company Highlights Financials Outlook Q&A profile first three first three months 2022 months 2022 3
Slide 4: Profile
Profile IMCD is a market leader in the sales, marketing and distribution of speciality chemicals and ingredients. Highlights: ● Formulatory and solutions provider ● Comprehensive and complementary product portfolio ● Multi-territory distribution management in EMEA, Asia-Pacific and Americas ● Headqu
Slide 5: Highlights first three months 2022
Company Highlights Financials Outlook Q&A profile first three first three months 2022 months 2022 5
Slide 6: Highlights first three months 2022
Highlights first three months 2022 GROSS PROFIT Gross profit growth of 40% to EUR 277 million (+36% on a constant currency basis) OPERATING EBITA Operating EBITA increase of 59% to EUR 140 million (+54% on a constant currency basis) NET RESULT Net result increase of 68% to EUR 79 million (+62% on a
Slide 7: Highlights – M&A
Highlights first three months 2022 – M&A EMEA • Acquisition of Polychem Handelsges.m.b.H. (“POLYchem”), a leading provider of chemical raw materials and additives in Austria and Southeast Europe (8 February 2022) • Acquisition of Evenlode Foods Ltd (“Evenlode”). Evenlode is active in speciality food
Slide 8: Financials first three months 2022
Company Highlights Financials Outlook Q&A profile first three first three months 2022 months 2022 8
Slide 9: Financials: Key figures
Financials first three months 2022 Key figures Jan.1 - Mar. 30 Jan.1 - Mar. 31 Change Change % Fx adj. Change 2022 2021¹ EUR million Revenue 1.107 810 297 37% 32% Gross profit 277 198 79 40% 36% Gross profit in % of revenue 25,1% 24,4% 0,7% Operating EBITA 140 88 52 59% 54% Operating EBITA in % of r
Slide 10: Financials: Income statement
Financials first three months 2022 Income statement Asia Holding EUR million EMEA Americas Pacific companies Total Gross profit 2022 136 85 57 277 2021 100 57 41 198 ∆ reported 36% 48% 40% 40% ∆ constant currency 37% 36% 34% 36% Gross profit as a % of revenue 2022 26.5% 23.6% 24.3% 25.1% 2021 25.5%
Slide 11: Financials: Free cash flow
Financials first three months 2022 Free cash flow Jan.1 - Mar. 31 Jan.1 - Mar. 30 Change Change % EUR million 2022 2021¹ Operating EBITA 140 88 52 59% Depreciation 7 7 0 Operating EBITDA 147 95 52 55% Share based payments 1 1 0 IAS 17 lease payments (6) (5) (0) Adjusted operating EBITDA 143 90 53 58
Slide 12: Financials: Net debt/leverage
Financials first three months 2022 Net debt/leverage 31 December 31 March 31 March 2022 2021¹ 2021¹ EUR million Reported Net Debt 1.039 940 745 Reported leverage ratio: Reported (incl. full year impact of acquisitions) 2,2 2,3 2,3 Leverage ratio based on loan documentation: Actual based on loan docu
Slide 13: Outlook
Company Highlights Financials Outlook Q&A profile first three first three months 2022 months 2022 13
Slide 14: Outlook
Outlook IMCD operates in different, often fragmented market segments in multiple geographic regions, connecting many customers and suppliers across a very diverse product range. In general, results are impacted by macroeconomic conditions and developments in specific industries. Results can be influ
Slide 15: Q&A
Company Highlights Financials Outlook Q&A profile first three first three months 2022 months 2022 15
Slide 16: Disclaimer
Disclaimer The content in this presentation is provided to you by IMCD N.V. (“IMCD”) and intended for your personal information only. All information appearing herein is based on our present knowledge and experience (“as is”) and IMCD makes no representations as to its accuracy or sufficiency. To th